Clinical Trials for Bladder Cancer (TCC)
Transitional cell carcinoma (TCC) is the most common bladder cancer in dogs and cats, arising from the transitional epithelium of the urinary tract. In dogs it particularly affects Scottish Terriers, Beagles, and Shetland Sheepdogs. Clinical trials at accredited veterinary universities are investigating targeted therapies, immunotherapy, and new drug combinations that may be available at reduced or no cost.
11 active trials currently enrolling
Trials available at institutions in:
Understanding Bladder Cancer (Transitional Cell Carcinoma - TCC) in Pets
Transitional cell carcinoma (TCC) grows from the lining of the bladder and urinary tract and is the most common bladder cancer in both dogs and cats. It tends to interfere with urination and can spread to nearby lymph nodes.
Who it tends to affect
- Typical size: Affects both dogs and cats; in dogs, small-to-medium breeds are seen more often
- Typical age: Most commonly diagnosed in older animals
Breeds it's seen in more often
Scottish Terriers, Beagles, Shetland Sheepdogs.
This is which breeds tend to develop bladder cancer (transitional cell carcinoma - tcc) — not a list of who can join a trial. See eligibility below.
Can my pet join — does breed matter?
Trials typically enroll based on diagnosis, tumor location within the urinary tract, and prior treatment. All breeds of dogs and cats meeting study criteria are generally eligible. The listed breeds have higher rates of this cancer in dogs but no trial requires or excludes a specific breed.
Most trials are open to all breeds and set requirements by size, weight, age, and diagnosis instead. Our matching service checks your pet's specific details against each study's actual requirements.
Where Bladder Cancer (Transitional Cell Carcinoma - TCC) Trials Are Running
Active research locations are spread across the country. Current coverage by region:
States with active sites include: MO, WI, IN, CO, KS, GA, CA, IL, NC, OH. We expand the search to nearby states when there's no local match.
What Bladder Cancer (Transitional Cell Carcinoma - TCC) Trials Typically Cost
Many trials cover part or all of treatment costs. Of the 11 trials we're currently tracking for bladder cancer (transitional cell carcinoma - tcc):
The trials themselves are run by research institutions — we don't charge for them. Funding status changes as studies open and close, so we confirm current coverage when we match your pet.
What Bladder Cancer (Transitional Cell Carcinoma - TCC) Research Is Focused On
Current studies for bladder cancer (transitional cell carcinoma - tcc) are exploring approaches like:
- •Targeted drug therapy
- •Anti-inflammatory drug combinations
- •New chemotherapy approaches
- •Immunotherapy
How it works
Tell us about your pet
Share the diagnosis, your pet's age and size, and your location. It takes a few minutes — no account needed.
We research current trials
We check open studies against your pet's actual eligibility — diagnosis, stage, location, and prior treatment. Most matches come back in 2–3 days.
You get your matches
A personalized list of trials your pet may qualify for, with locations, funding status, and exactly how to enroll.
The trials themselves are free and run by research institutions. Our fee covers the research and eligibility matching — and if we don't find any matches for your pet, you don't pay.
Find trials for my pet with Bladder Cancer (Transitional Cell Carcinoma - TCC) now
Our matching service screens all 11 active Bladder Cancer (Transitional Cell Carcinoma - TCC) trials against your pet’s specific profile — age, breed, stage, and location.
$7 to see your matches · $23 only if trials are found
Check My Pet’s Eligibility Now →Find Trials for Your Pet
Our free matching service screens 147 active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet